Tessera Therapeutics is a biotechnology company pioneering a new approach to genome engineering through the development of its Gene Writing™ and delivery platforms, with the aim to unlock broad new therapeutic frontiers.
Our mission is to cure disease by writing in the code of life. We believe our Gene Writing™ and delivery platforms will enable transformative genetic medicines to treat monogenic diseases, cancer and potentially autoimmune and other diseases.
Discover your future at Tessera.
Company Details
- Employees
- 326
- Address
- Somerville, Ma 02143, Us
- in****@****atx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- tesseratx.com
- HQ
- Somerville, MA
Tessera Therapeutics Questions
Tessera Therapeutics's website is tesseratx.com
Tessera Therapeutics's LinkedIn profile is https://www.linkedin.com/company/tessera-therapeutics
Tessera Therapeutics has
326 employees.
View email and phone details for 326
employees at Tessera Therapeutics.
Tessera Therapeutics's industry is
Biotechnology Research
Tessera Therapeutics's top competitors are
Nuvalent, Inc.,
Verve Therapeutics,
Fable Therapeutics,
Kalvista Pharmaceuticals, Inc.,
Dyno Therapeutics,
Myrobalan Therapeutics,
Intellia Therapeutics, Inc.,
Nvelop Therapeutics,
Rapport Therapeutics,
Beam Therapeutics.
Tessera Therapeutics's support email address is info@tesseratx.com
Tessera Therapeutics's categories are Biotechnology Research
